LFWD
Lifeward Ltd.0.6398
+0.0187+3.01%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
11.70MP/E (TTM)
-Basic EPS (TTM)
-2.91Dividend Yield
0%Recent Filings
10-Q
8-K
8-K
Lifeward's Q3 prelims show slim margin
Lifeward Ltd. disclosed preliminary Q3 2025 revenue of approximately $6.2 million, edging out operating expenses of $5.8 million to $5.9 million. Cash and equivalents stood at $2.0 million as of September 30. These figures, subject to final review, signal a slim operating margin amid tight liquidity. Final results await the 10-Q filing.
8-K
Lifeward Q2 revenue dips, cash improves
Lifeward Ltd. reported Q2 2025 revenue of $5.7 million, down 15% from $6.7 million in Q2 2024 but up 14% from Q1 2025, amid record ReWalk placements for Medicare beneficiaries and over 130 qualified U.S. leads. Cash burn improved to $3.9 million from $5.6 million year-over-year, fueled by efficiencies and in-house manufacturing shift, while a $2.8 million goodwill impairment widened net loss to $6.6 million. New CEO Mark Grant and CFO Almog Adar aim to drive growth. Guidance targets $24–$26 million revenue and $12–$14 million non-GAAP net loss for 2025.
10-Q
Q2 FY2025 results
Lifeward's Q2 revenue dipped 14.7% y/y to $5.7M, yet gross margins climbed to 43.9% from 41.1%, buoyed by lower production costs after shifting ReWalk manufacturing in-house and closing the Fremont facility. Operating loss widened to $6.6M from $4.4M, hit by a $2.8M goodwill impairment from a sagging stock price, while net loss hit $6.6M or $(0.58) per share on 11.2M diluted shares—anti-dilution kept it from deeper red. Cash burn eased to $3.9M quarterly, with $5.1M on hand funding ops into Q4 2025, bolstered by $7.8M from equity raises including a June public offering. The AlterG acquisition from August 2023 added $19M cash outlay and potential earnouts, but targets missed, wiping the liability. Nasdaq delisting looms if shares stay below $1.
BWAY
Brainsway Ltd.
16.87-0.47
DHAI
DIH Holding US, Inc.
0.75+0.16
DYNT
Dynatronics Corp.
0.04+0.00
EKSO
Ekso Bionics Holdings, Inc.
4.70+0.05
EW
Edwards Lifesciences Corporatio
85.32+1.94
INMD
InMode Ltd.
14.48+0.15
LIVN
LivaNova PLC
63.08+0.02
MYO
Myomo Inc.
1.04+0.04
ONWRF
ONWARD MEDICAL NV
5.15+0.00
STME
Stimcell Energetics, Inc.
0.37-0.04